Trends in the use of short‐course radiation therapy for rectal cancer in New South Wales, Australia

Trends in the use of short‐course radiation therapy (RT) for rectal cancer in Australia are unknown. The purpose of this study was to compare short‐course RT and long‐course chemoradiation (CRT) utilisation in the neoadjuvant treatment of rectal cancer in New South Wales (NSW).

[1]  T. Conroy,et al.  Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. , 2021, The Lancet. Oncology.

[2]  Charles R. Thomas,et al.  Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. , 2020, Practical radiation oncology.

[3]  W. Bemelman,et al.  Nationwide analysis of hospital variation in preoperative radiotherapy use for rectal cancer following guideline revision. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  M. Barton,et al.  Estimating the cost of radiotherapy for 5-year local control and overall survival benefit. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  D. Trifiletti,et al.  Short‐course Versus Long‐course Neoadjuvant Therapy for Non‐metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database , 2018, Clinical colorectal cancer.

[6]  E. B. Butler,et al.  Trends and disparities in the utilization of hypofractionated neoadjuvant radiation therapy for rectal cancer in the United States. , 2018, Journal of gastrointestinal oncology.

[7]  L. Wyrwicz,et al.  Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  D. Joseph,et al.  Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04) , 2017, Annals of surgery.

[9]  P. Quirke,et al.  Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

[10]  D. Aust,et al.  Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer. , 2016, European journal of cancer.

[11]  D. Goldstein,et al.  The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04). , 2016, European journal of cancer.

[12]  D. Goldstein,et al.  Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Mariusz Pawlak,et al.  Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  K. Bujko,et al.  Long‐term results of a randomized trial comparing preoperative short‐course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer , 2006, The British journal of surgery.

[15]  K. Bujko,et al.  Postoperative complications in patients irradiated pre‐operatively for rectal cancer: report of a randomised trial comparing short‐term radiotherapy vs chemoradiation , 2005, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[16]  H. Quan,et al.  New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. , 2004, Journal of clinical epidemiology.